Related articles
-
NewsResearchers find increased bacteria infection in patients with chronic lung disease
A new study has found that people with bronchiectasis and chronic sinus disease were more likely to have mucus samples that tested positive for Pseudomonas aeruginosa. It suggests that doctors caring for patients with bronchiectasis may need to pay closer attention to sinus disease and bacterial testing.
-
NewsDiseases can spread between apartments via shared ventilation, study shows
Airborne diseases like measles, influenza and COVID-19 can easily spread between units in multi-family buildings via a type of bathroom ventilation system commonly used around the world, new research suggests.
-
NewsFriendly skin bacteria offer hope to beat eczema
Friendly skin bacteria could hold the key to stopping eczema in its tracks, according to researchers. A new study reveals harmless microbes living on our skin release powerful molecules that can shut down the inflammatory chaos triggered by Staphylococcus aureus, the bug long known to wreak havoc in eczema.
More from News
-
NewsExperts call on WHO to revisit its approach to airborne risk in light of hantavirus outbreak
In light of the hantavirus outbreak, public health experts have called on the World Health Organization (WHO) to shift its default response to emerging respiratory viruses. The starting point should not be to downplay the risk of airborne transmission until it is definitively proven, they warned.
-
NewsMarine-inspired sunscreen ingredient made by E. coli
Researchers have engineered microbial “cell factories” to sustainably produce the UV-protective compound gadusol, which could eventually serve as a sunscreen ingredient and an antioxidant additive. Gadusol, found in the eggs of various fish and other marine organisms, helps protect against ultraviolet damage.
-
NewsFlawed but correctable research hindered progress in infection-triggered chronic conditions
Researchers contend that studies of infection-associated chronic illnesses such as Lyme disease and COVID-19 suffer recurring problems such as the failure to prove participants have the relevant pathogen.
No comments yet